Nuvectis Pharma Inc
NASDAQ:NVCT
Income Statement
Earnings Waterfall
Nuvectis Pharma Inc
Income Statement
Nuvectis Pharma Inc
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(19)
|
(20)
|
(23)
|
(23)
|
(23)
|
(23)
|
(22)
|
(20)
|
(20)
|
(21)
|
(23)
|
(26)
|
|
| Selling, General & Administrative |
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
|
| Research & Development |
(13)
|
(14)
|
(16)
|
(16)
|
(15)
|
(16)
|
(15)
|
(13)
|
(13)
|
(14)
|
(15)
|
(18)
|
|
| Operating Income |
(19)
N/A
|
(20)
-6%
|
(23)
-11%
|
(23)
-1%
|
(23)
0%
|
(23)
-1%
|
(22)
+5%
|
(20)
+8%
|
(20)
+2%
|
(21)
-6%
|
(23)
-9%
|
(26)
-15%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Pre-Tax Income |
(19)
N/A
|
(20)
-6%
|
(22)
-11%
|
(22)
N/A
|
(22)
+0%
|
(22)
-1%
|
(21)
+6%
|
(19)
+8%
|
(19)
+2%
|
(20)
-6%
|
(22)
-9%
|
(25)
-15%
|
|
| Net Income | |||||||||||||
| Income from Continuing Operations |
(19)
|
(20)
|
(22)
|
(22)
|
(22)
|
(22)
|
(21)
|
(19)
|
(19)
|
(20)
|
(22)
|
(25)
|
|
| Net Income (Common) |
(19)
N/A
|
(20)
-6%
|
(22)
-11%
|
(22)
N/A
|
(22)
+0%
|
(22)
-1%
|
(21)
+6%
|
(19)
+8%
|
(19)
+2%
|
(20)
-6%
|
(22)
-9%
|
(28)
-26%
|
|
| EPS (Diluted) |
-1.51
N/A
|
-1.37
+9%
|
-1.47
-7%
|
-1.38
+6%
|
-1.43
-4%
|
-1.35
+6%
|
-1.24
+8%
|
-1.13
+9%
|
-1.11
+2%
|
-1.01
+9%
|
-1.03
-2%
|
-1.22
-18%
|
|